May 11, 2020 / 12:49 PM / 22 days ago

BRIEF-AMAG Pharma Expects To Record One-Time Restructuring Charge Of About $8 Million In Q2 Of 2020

May 11 (Reuters) - AMAG Pharmaceuticals Inc:

* AMAG PHARMACEUTICALS-EXPECTS TO RECORD ONE-TIME RESTRUCTURING CHARGE OF ABOUT $8 MILLION PRIMARILY RELATED TO SEVERANCE, RELATED BENEFITS IN Q2 OF 2020

* AMAG PHARMACEUTICALS INC - EXPECTS THIS WORKFORCE REDUCTION TO BE SUBSTANTIALLY COMPLETED BY END OF Q2 OF 2020

* AMAG PHARMACEUTICALS INC - ON MAY 8, CO DISMISSED PRICEWATERHOUSECOOPERS LLP AS ITS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

* AMAG PHARMACEUTICALS- ON MAY 8, APPOINTED DELOITTE & TOUCHE LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR ENDING DEC 31, 2020 Source text: (bit.ly/2AlFYfr) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below